Kaufman S S, Tuma D J, Sorrell M F, Vanderhoof J A
Am J Physiol. 1984 Sep;247(3 Pt 1):G311-8. doi: 10.1152/ajpgi.1984.247.3.G311.
Colchicine and other antimicrotubular drugs have been shown to impair plasma protein secretion by fetal rat liver at late gestation (day 21) markedly less than by the mature organ. In the present study, the effect of colchicine on plasma protein secretion by liver slices was determined at several times during rat development. Secretion of [14C]leucine-labeled albumin and [3H]glucosamine-labeled glycoproteins was only minimally impaired (20%) by colchicine (50 microM) on gestation day 19. Inhibition of protein secretion increased to about 40% just before birth and remained unchanged throughout the perinatal period. Inhibition increased thereafter until the maximum effect (75%) was first observed 28 days after birth. Studies in which [3H]-colchicine was used indicated that neither reduced colchicine levels in tissue nor reduced affinity of tubulin for colchicine caused the diminished impairment of secretion in immature liver. These findings suggest that participation of microtubules in liver plasma protein secretion is reduced during development and that full participation is delayed beyond the perinatal period in this species.
秋水仙碱和其他抗微管药物已被证明,与成熟器官相比,其对妊娠晚期(第21天)胎鼠肝脏血浆蛋白分泌的损害明显较小。在本研究中,在大鼠发育的几个阶段测定了秋水仙碱对肝切片血浆蛋白分泌的影响。在妊娠第19天,秋水仙碱(50微摩尔)对[14C]亮氨酸标记的白蛋白和[3H]葡糖胺标记的糖蛋白分泌的损害最小(20%)。在出生前,蛋白质分泌的抑制作用增加到约40%,并且在围产期保持不变。此后抑制作用增加,直到出生后28天首次观察到最大作用(75%)。使用[3H] - 秋水仙碱的研究表明,组织中秋水仙碱水平降低和微管蛋白对秋水仙碱的亲和力降低均不会导致未成熟肝脏中分泌损害的减少。这些发现表明,在发育过程中微管对肝脏血浆蛋白分泌的参与减少,并且在该物种中,完全参与被推迟到围产期之后。